CDXS compared with ETON: revenue, margins and what each company keeps, and the suppliers and customers both name

CDXSCodexis, Inc.

Mkt capRevenueRevenue

ETONEton Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

CDXSCodexis, Inc.

ETONEton Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CDXS

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±34.8%▲+8.11%×0.23

May 8 '26±27.8%▲+10.47%×0.38

Q1 FY26±46.9%▲+34.65%×0.74

Q3 FY25±23.6%▼−16.95%×0.72

ETON

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.6%▲+44.26%×4.18

May 15 '26±6.6%▲+1.00%×0.15

= impliedCDXS realized, solidETON realized, hatchedOne scale, both sides: full bar = 47%× = |realized| ÷ impliedSource: market data

Q1 FY26

±10.6%

▲+7.46%

×0.71

Q3 FY25±18.1%▼−11.70%×0.65

CDXSCodexis, Inc.

1.19▼−2.41%· post 1.20

Mkt cap$108.4MRevenue$15MQ2 FY26Revenue$59MFY24

ETONEton Pharmaceuticals, Inc.

52.20▼−2.75%· post 52.20

ClosedOct 30 '26

Mkt cap$1.5BRevenue$38MQ2 FY26Revenue$80MFY25

Compare

ClosedOct 30 '26

CDXSCodexis, Inc.

ETONEton Pharmaceuticals, Inc.

1.19▼−2.41%post 1.20

Price

52.20▼−2.75%post 52.20

$108.4M

Mkt cap

$1.5B

Q2 FY26$15M

Revenue

$38MQ2 FY26

FY24$59M

Revenue

$80MFY25

CDXS1.19▼−2.41%vsETON52.20▼−2.75%ClosedOct 30 '26